Skip to main content
Notice2026-18745

Agency Forms Undergoing Paperwork Reduction Act Review

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 14, 2026

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 176 (Monday, September 14, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 176 (Monday, September 14, 2026)]
[Notices]
[Pages 58123-58124]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-18745]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-26-1469]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``2026 Ebola Entry Screening, Monitoring, & 
Traveler Feedback'' to the Office of Management and Budget (OMB) for 
review and approval. CDC previously published a ``Proposed Data 
Collection Submitted for Public Comment and Recommendations'' notice on 
June 2, 2026 to obtain comments from the public and affected agencies. 
CDC received one comment related to the previous notice. This notice 
serves to allow an additional 30 days for public and affected agency 
comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    2026 Ebola Entry Screening, Monitoring, & Traveler Feedback (OMB 
Control No. 0920-1469, Exp. 10/31/2026)--Revision--National Center for 
Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The Centers for Disease Control and Prevention (CDC), National 
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division 
of Global Migration Health (DGMH) requests approval for a Revision of 
an existing information collection (OMB Control No. 0920-1469). Section 
361 of the Public Health Service (PHS) Act (42 U.S.C. 264) authorizes 
the Secretary of Health and Human Services to make and enforce 
regulations necessary to prevent the introduction, transmission or 
spread of communicable diseases from foreign countries into the United 
States. Under its delegated authority, DGMH works to fulfill this 
responsibility through a variety of activities, including the operation 
of Port Health Stations at ports of entry and administration of foreign 
quarantine regulations; 42 Code of Federal Regulation part 71, 
specifically 42 CFR 71.20--Public health prevention measures to detect 
communicable disease.
    This information collection concerns CDC's statutory and regulatory 
authority related to conducting public health screening of travelers 
upon arrival to the United States and assessing individual travelers 
for public health risk following a report of illness from a conveyance 
and CDC's responsibility to ensure the successful implementation of 
traveler monitoring to prevent the transmission or spread of 
communicable diseases into the United States. On May 18, 2026, CDC 
published an Order under the Public Health Service Act Suspending 
Introduction of Certain Persons From Countries Where a Communicable 
Disease Exists. The Order was amended on May 22, 2026. An Order 
continuing the suspension of the right to introduce specified foreign 
nationals into the United States was issued on June 21, 2026, July 13, 
2026, and most recently on August 12, 2026. The order issued on August 
12 will be in effect for 30 days. Exceptions are included for U.S. 
citizens, U.S. nationals, certain U.S. government personnel and 
military, case-by-case humanitarian or law enforcement exceptions, and 
Department of Homeland Security (DHS)-approved entry processes with 
CDC-documented mitigation protocols.
    CDC relies on its federal partners in the Department of Homeland 
Security (DHS) to assist in the screening process because of their 
presence at the ports of entry. DHS will refer travelers that have been 
to Ebola outbreak areas to another location at the airport where CDC 
will

[[Page 58124]]

ask initial health screening questions to determine if a more in-depth 
public health risk assessment is necessary. CDC develops the tools and 
training to facilitate this screening process and works to ensure that 
any individual who is identified by DHS as being from the outbreak area 
is further evaluated. This may involve medical evaluation by CDC 
followed by transport to a healthcare facility if somebody is 
identified as being ill; a location for quarantine at or near that 
location; and/or communication via phone with CDC or state and local 
health departments to see if the travelers develop symptoms after 
arrival.
    On May 17, 2026, an outbreak of Ebola disease caused by Bundibugyo 
virus was detected in the Democratic Republic of the Congo (DRC) and 
Uganda. On May 20, 2026, the DHS published Arrival Restrictions 
Applicable to Flights Carrying Persons Who Have Recently Traveled From 
or Were Otherwise Present Within the Democratic Republic of the Congo 
(DRC), Uganda, or South Sudan. Airlines are instructed to redirect 
flights carrying persons who have recently traveled from or were 
otherwise present within DRC, Uganda, and South Sudan in the previous 
21 days to Washington-Dulles International Airport (IAD). U.S. Customs 
and Border Protection (CBP) issued a memo on May 22, 2026, modifying 
the list of designated airports to include Hartsfield-Jackson Atlanta 
International Airport (ATL) and George Bush Intercontinental Airport 
(IAH). On May 26, 2026, CBP further expanded the list of airports to 
include John F. Kennedy International Airport (JFK). CDC is conducting 
public health entry screening at designated U.S. airports of travelers 
coming from DRC, Uganda, and South Sudan. The purpose of public health 
entry screening is to detect ill travelers or travelers arriving from 
regions affected by the outbreak who are at risk of becoming ill with 
Ebola to facilitate post-arrival management.
    CDC will utilize information collected during public health entry 
screening to determine which travelers should be monitored for Ebola 
symptoms in accordance with CDC's interim recommendations for post-
arrival public health management of travelers from the outbreak area. 
CDC is currently sharing contact information and initial public health 
assessment of exposure risk for travelers who have been in areas 
affected by the outbreak during the 21 days before their arrival in the 
United States with state and local health departments through existing 
data-sharing infrastructure. State and local health departments utilize 
the contact information provided by CDC to prioritize and identify the 
level of follow-up needed based on the level of risk of exposure to 
Ebola and determine if additional risk assessment and/or targeted 
public health measures are necessary. This coordination is necessary to 
facilitate post-arrival public health management as specified in CDC 
interim guidance.
    At the end of the 21-day monitoring period, CDC will send a final 
survey to travelers intended to evaluate the impact of rerouting and 
public health entry screening on travelers. The results of this final 
survey will allow CDC to identify the most efficient channels for 
reaching travelers and refine public health messaging for travelers 
coming from the outbreak area.
    An Emergency package was approved for collection of data on 5/20/
2026. CDC requests OMB approval for the continued collection of data 
under OMB Control No. 0920-1469--2026 Ebola Entry Screening, 
Monitoring, & Traveler Feedback. The total estimated annual burden 
requested is 25,171 hours. There is no cost to respondents other than 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Number      Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent       (in hrs.)
----------------------------------------------------------------------------------------------------------------
Traveler..............................  2026_EbolaBVD_IPHA......          54,750               1           10/60
Traveler..............................  Follow up PHA_2026 Ebola           5,475               1           20/60
                                         DRC.
Traveler..............................  2026 Ebola Response               54,750               1           15/60
                                         Survey of Travelers.
Travelers requesting exceptions to      Initial PHA _2026 Ebola              500               1               1
 travel restrictions.                    DRC.
Airlines..............................  Airline Feedback                     100               1           20/60
                                         Survey_Ebola 2026.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2026-18745 Filed 9-11-26; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>
Indexed from Federal Register on September 14, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.